Skip to main content
Clinical Trials/DRKS00025079
DRKS00025079
Completed
Not Applicable

Pilot study on the use of albumin function test by ESR method in ICU patients for the detection of sepsis/septic shock and its follow-up.

MedInnovation GmbH0 sites26 target enrollmentApril 28, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
A41
Sponsor
MedInnovation GmbH
Enrollment
26
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 28, 2021
End Date
January 12, 2022
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Sepsis Group
  • \- At least 18 years
  • \- Patients diagnosed with sepsis as defined by Sepsis\-3 (life\-threatening organ dysfunction caused by a dysregulated immune response to infection.
  • Clinical Criteria: SOFA score \=2, screening tool: qSOFA at least 2 of 3 (AF\=22/min; RR syst. \=100mmHg; impaired mental status: GCS\<15\).
  • Septic shock
  • \- At least 18 yrs.
  • \- Septic shock \= sepsis \+ cardiovascular collapse unresponsive to hydration and vasopressors necessary to maintain MAP \> 65mmHg, lactate \= 2 mmol/L
  • Control group
  • \- At least 18 yrs.
  • \- Patient \-of the intensive care unit of the Internal Medicine of the University Medical Center Rostock without sepsis / septic shock.

Exclusion Criteria

  • Extracorporeal treatment with citrate anticoagulation ongoing at the time of blood collection;
  • Albumin substitution;
  • More than 500ml of FFP or red cell concentrate 12 hours prior to blood collection;
  • Patients with liver cirrhosis;

Outcomes

Primary Outcomes

Not specified

Similar Trials